Hunan Fangsheng Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 422.8 million compared to CNY 336.91 million a year ago. Revenue was CNY 422.8 million compared to CNY 336.91 million a year ago. Net income was CNY 34.21 million compared to CNY 23.53 million a year ago. Basic earnings per share from continuing operations was CNY 0.0797. Diluted earnings per share from continuing operations was CNY 0.0797.